Wilmington, DE, United States of America

John Francis McElroy

USPTO Granted Patents = 33 

Average Co-Inventor Count = 2.1

ph-index = 7

Forward Citations = 184(Granted Patents)


Location History:

  • Alhambra, CA (US) (1994)
  • Wilmington, DE (US) (2001 - 2021)

Company Filing History:


Years Active: 1994-2021

Loading Chart...
33 patents (USPTO):Explore Patents

Title: John Francis McElroy: Innovator in Cannabinoid Research

Introduction

John Francis McElroy, residing in Wilmington, DE, is a notable inventor with a remarkable portfolio of 32 patents. His contributions to the field of cannabinoid research have positioned him as a key player in developing innovative therapeutic solutions.

Latest Patents

Among his latest groundbreaking patents are "Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers." This invention introduces novel, diastereomeric pyrazolines that function as cannabinoid receptor blockers, providing pharmaceutical compositions and methods for treating various health conditions, such as obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and cancers. Additionally, he has patented similar applications focused specifically on metabolic disorders, reaffirming his dedication to addressing significant health challenges.

Career Highlights

Throughout his career, John has held influential positions at various esteemed organizations. Notably, he has worked at Jenrin Discovery, Inc., and Wisys Technology Foundation, Inc., where he contributed to advancing research and development in cannabinoid applications.

Collaborations

In his journey, John has collaborated with distinguished peers, including Robert J Chorvat and Rajagopalan Parthasarathi. These partnerships have enhanced his research efforts and expanded the impact of his inventions.

Conclusion

John Francis McElroy's work exemplifies the innovative spirit inherent in modern scientific research. His extensive roster of patents underscores his commitment to finding solutions for serious medical conditions, particularly in the realm of cannabinoid therapies. Through his ongoing contributions, McElroy continues to shape the future of health-related innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…